GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » E10

Polaris AI Pharma (XKRX:041910) E10 : ₩505.44 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Polaris AI Pharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Polaris AI Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was ₩100.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩505.44 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Polaris AI Pharma's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Polaris AI Pharma was 17.50% per year. The lowest was -8.30% per year. And the median was 11.90% per year.

As of today (2025-04-06), Polaris AI Pharma's current stock price is ₩5580.00. Polaris AI Pharma's E10 for the quarter that ended in Dec. 2024 was ₩505.44. Polaris AI Pharma's Shiller PE Ratio of today is 11.04.

During the past 13 years, the highest Shiller PE Ratio of Polaris AI Pharma was 44.75. The lowest was 10.80. And the median was 18.43.


Polaris AI Pharma E10 Historical Data

The historical data trend for Polaris AI Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris AI Pharma E10 Chart

Polaris AI Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 645.89 627.84 492.97 498.46 505.44

Polaris AI Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 498.46 491.26 533.16 527.86 505.44

Competitive Comparison of Polaris AI Pharma's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Polaris AI Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polaris AI Pharma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Polaris AI Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Polaris AI Pharma's Shiller PE Ratio falls into.


;
;

Polaris AI Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Polaris AI Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=100/121.1352*121.1352
=100.000

Current CPI (Dec. 2024) = 121.1352.

Polaris AI Pharma Quarterly Data

per share eps CPI Adj_EPS
201503 -35.000 99.721 -42.516
201506 40.000 100.051 48.430
201509 -26.000 100.111 -31.460
201512 -59.000 100.220 -71.313
201603 30.000 100.561 36.138
201606 18.000 100.791 21.633
201609 -3.000 101.461 -3.582
201612 306.000 101.561 364.975
201703 -22.000 102.851 -25.911
201706 80.000 102.611 94.442
201709 55.000 103.491 64.377
201712 116.000 102.991 136.436
201803 38.000 104.101 44.218
201806 413.000 104.130 480.445
201809 -5.000 105.651 -5.733
201812 126.000 104.351 146.267
201903 40.000 104.491 46.372
201906 843.000 104.881 973.647
201909 237.000 105.200 272.899
201912 183.000 105.121 210.878
202003 170.000 105.354 195.464
202006 413.000 105.112 475.958
202009 200.000 106.198 228.132
202012 565.000 105.765 647.106
202103 211.000 107.357 238.079
202106 208.000 107.579 234.211
202109 193.000 108.759 214.962
202112 -23.000 109.676 -25.403
202203 88.000 111.848 95.307
202206 -90.000 114.072 -95.572
202209 110.000 114.715 116.156
202212 -653.000 115.179 -686.767
202303 155.000 116.507 161.157
202306 229.000 117.182 236.725
202309 90.000 118.964 91.643
202312 -147.000 118.837 -149.843
202403 -80.000 120.123 -80.674
202406 210.000 120.007 211.974
202409 85.000 120.861 85.193
202412 100.000 121.135 100.000

Add all the adjusted EPS together and divide 10 will get our e10.


Polaris AI Pharma  (XKRX:041910) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Polaris AI Pharma's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=5580.00/505.44
=11.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Polaris AI Pharma was 44.75. The lowest was 10.80. And the median was 18.43.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Polaris AI Pharma E10 Related Terms

Thank you for viewing the detailed overview of Polaris AI Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Polaris AI Pharma Business Description

Traded in Other Exchanges
N/A
Address
25 Balangongdan-ro, Hyangnam-eup, Gyeonggi-do, Hwaseong-si, KOR
Polaris AI Pharma Corp is engaged in the production of raw pharmaceutical ingredients. It focuses on generic drugs and produces about 40 types of raw medicines, including asthma treatments, gastric ulcer treatments, and alcohol dependence treatments, and supplies them domestically and internationally.

Polaris AI Pharma Headlines

No Headlines